George Craig Shapiro - Aug 19, 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Medical Officer, Director
Signature
/s/ George Craig Shapiro
Stock symbol
OCEL
Transactions as of
Aug 19, 2021
Transactions value $
$0
Form type
4
Date filed
8/24/2022, 04:54 PM
Previous filing
Jun 21, 2021
Next filing
Nov 2, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCEL Warrant to Purchase Common Stock Award +3.15M 3.15M Aug 19, 2022 Common Stock 3.15M $0.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Warrants were issued to the Reporting Person in consideration of the Reporting Person having agreed with the Issuer to waive payment of certain accrued but unpaid consulting fees due him as of July 31, 2022 and to terminate the consulting arrangement with the Issuer.